Accessing compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes. However, gaps between clinical trial data (CTD) and real world data (RWD) make it difficult to fully understand long term outcomes and therapeutic efficacy.
Data linkage is a cutting-edge innovation that unlocks a new frontier of enhanced evidence generation by linking CTD and RWD at the patient level. While some clinical development teams have made progress toward data linkage, data privacy and accessibility pose major challenges. Some have attempted to link data in-house, but often struggle to ensure that their systems meet complicated security and privacy requirements. In-house data linkage also risks unblinding trials and reidentifying patients. Other organizations are developing custom solutions for specific trials, but face difficulties scaling across a sponsor’s entire portfolio. Inability to scale leads to inefficiencies, greater costs, and increased patient and site burden.
Read More: https://techmonitor.ai/whitepapers/connecting-patient-level-clinical-trial-data-to-real-world-data